Skip to main content
. 2022 Jul 26;10(4):e01014-22. doi: 10.1128/spectrum.01014-22

TABLE 3.

Performance of the MGparC-AsyHRM method with 105 fully characterized M. genitalium clinical samples

AMR position (no. of samples) Consistency with Sanger sequence method (%) No. of samples that failed to provide valid data/total no. of samples (%) No. of samples successfully producing valid data for different genomic copy ranges/total no. of samples (%) with:
>2,000 copies/reaction
200–2,000 copies/reaction
20–200 copies/reaction
<20 copies/reaction
Assay 1 Assay 2 Assay 1 Assay 2 Assay 1 Assay 2 Assay 1 Assay 2
WT (31) 28/29 (96.6) 2/31 (6.5) 3/3 (100) 3/3 (100) 5/5 (100) 5/5 (100) 18/18 (100) 17/18 (94.4) 5/5 (100) 4/5 (80)
S83I (50) 43/43 (100) 7/50 (14) 6/6 (100) 6/6 (100) 11/11 (100) 11/11 (100) 20/20 (100) 20/20 (100) 9/13 (69.2) 9/13 (69.2)
S83N (11) 10/10 (100) 1/11 (9.1) 1/1 (100) 1/1 (100) 1/1 (100) 1/1 (100) 4/4 (100) 4/4 (100) 4/5 (80) 4/5 (80)
S83R (1) 1/1 (100) 0/1 (0) 0/0 (100) 0/0 (100) 0/0 (100) 0/0 (100) 1/1 (100) 1/1 (100) 0/0 (100) 0/0 (100)
D87N (7) 5/6 (83.3) 1/7 (14.3) 0/0 (100) 0/0 (100) 0/0 (100) 0/0 (100) 3/3 (100) 3/3 (100) 2/3 (66.7) 2/3 (66.7)
D87Y (4) 3/3 (100) 1/4 (25) 0/0 (100) 0/0 (100) 1/1 (100) 1/1 (100) 2/2 (100) 2/2 (100) 0/1 (0) 0/1 (0)
Rare type (1) 1/1 (100) 0/1 (0) 0/0 (100) 0/0 (100) 1/1 (100) 1/1 (100) 0/0 (100) 0/0 (100) 0/0 (100) 0/0 (100)
Total (n = 105) 91/93 (97.8) 12/105 (11.4) 11/11 (100) 11/11 (100) 19/19 (100) 19/19 (100) 48/48 (100) 47/48 (97.9) 20/27 (74.1) 19/27 (70)